Comparison of efficacy and complication rates after percutaneous coronary interventions in patients with and without renal insufficiency treated with abciximab

Am J Cardiol. 2002 Feb 15;89(4):450-2. doi: 10.1016/s0002-9149(01)02267-6.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Abciximab
  • Aged
  • Angina, Unstable / complications
  • Angina, Unstable / therapy
  • Angioplasty, Balloon, Coronary*
  • Antibodies, Monoclonal / therapeutic use*
  • Coronary Disease / complications*
  • Coronary Disease / therapy*
  • Coronary Stenosis / complications
  • Coronary Stenosis / therapy
  • Female
  • Humans
  • Immunoglobulin Fab Fragments / therapeutic use*
  • Male
  • Middle Aged
  • Myocardial Infarction / complications
  • Myocardial Infarction / therapy
  • Platelet Glycoprotein GPIIb-IIIa Complex / therapeutic use*
  • Renal Insufficiency / complications*

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin Fab Fragments
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Abciximab